Endothelial Expression of MHC Class II Molecules in Autoimmune Disease

E-ISSN： 1873-4286|10|2|129-143

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.10, Iss.2, 2004-01, pp. : 129-143

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Endothelial Chemokines in Autoimmune Disease

Current Pharmaceutical Design, Vol. 10, Iss. 2, 2004-01 ,pp. : 145-154

Bentham Science Publishers

Access to resources Recommend Favorite

Oxazole- and Imidazole-Based Ser-Leu Dipeptide Mimetics in Potent Inhibitors of Antigen Presentation by MHC Class II DR Molecules

By Sarabu Ramakanth Bolin David R. Campbell Robert Cooper Joel P. Cox Donald Gaizband Diana Makofske Raymond Nagy Zoltan Olson Gary L.

Drug Design and Discovery, Vol. 18, Iss. 1, 2002-03 ,pp. : 3-7

Taylor & Francis Ltd

Access to resources Recommend Favorite

Systemic Immunomodulation of Autoimmune Disease Using MHC-Derived Recombinant TCR Ligands

Current Drug Targets. Inflammation & Allergy, Vol. 4, Iss. 2, 2005-04 ,pp. : 185-193

Bentham Science Publishers

Access to resources Recommend Favorite

Gene Expression Profiles in Human Autoimmune Disease

Current Pharmaceutical Design, Vol. 9, Iss. 23, 2003-09 ,pp. : 1905-1917

Bentham Science Publishers

Access to resources Recommend Favorite

Differential expression of HLA class II genes associated with disease susceptibility and progression in rheumatoid arthritis

Arthritis & Rheumatism, Vol. 48, Iss. 10, 2003-10 ,pp. : 2779-2787

John Wiley & Sons Inc

Access to resources Recommend Favorite